Ildiko Mehes
Direttore/Membro del Consiglio presso Ironshore Therapeutics, Inc.
Provenienza dei contatti di primo grado di Ildiko Mehes
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Ironshore Therapeutics, Inc.
Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ildiko Mehes tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
BANK OF MONTREAL | Major Banks | Corporate Officer/Principal | |
DANAHER CORPORATION | Medical Specialties | Director of Finance/CFO | |
TRANSGLOBE ENERGY CO. | Integrated Oil | Director of Finance/CFO | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Chairman | |
BMO Capital Markets Corp. (Canada)
BMO Capital Markets Corp. (Canada) Investment Banks/BrokersFinance BMO Capital Markets Corp. (Canada) (BMO Capital Markets-Canada) is the Canadian brokerage arm of BMO Capital Markets Corp., a full-service financial services provider in the US. The firm was founded in 1817 and is a subsidiary of BMO Asset Management, Inc., which is owned by Bank of Montreal (NYSE, TSX: BMO) in Canada. Headquartered in Toronto, BMO Capital Markets-Canada provides full-service, institutional brokerage services to corporate, institutional and government clients around the world. | Investment Banks/Brokers | Director of Finance/CFO | |
AEROCRINE AB | Electronic Equipment/Instruments | Chief Executive Officer | |
TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
Canadian Opera Co.
Canadian Opera Co. Packaged SoftwareTechnology Services Canadian Opera Co. operates as an opera company. It enjoys an international reputation for artistic excellence and creative innovation. The company is headquartered in Toronto, Canada. | Packaged Software | Chairman | |
UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
KUNWHA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Myriad Energy Corp
Myriad Energy Corp Oil & Gas ProductionEnergy Minerals Part of Tajzha Ventures Ltd., Myriad Energy Corp explores for, produces, and develops oil and gas properties. | Oil & Gas Production | Director of Finance/CFO | |
Eagle Resources Ltd
Eagle Resources Ltd Oil & Gas ProductionEnergy Minerals Part of Osaka Gas Co., Ltd., Eagle Resources Ltd is an oil and Canadian gas exploration company. Eagle Resources was acquired by Wiser Oil Co. of Canada on June 28, 1994 for $72.50 million. | Oil & Gas Production | Director of Finance/CFO | |
Northstar Drilling Systems, Inc.
Northstar Drilling Systems, Inc. Contract DrillingIndustrial Services Part of NOV, Inc., Northstar Drilling Systems, Inc. provides oil and gas field drilling services. The company is based in Calgary, Canada. Northstar Drilling Systems was acquired by NQL Energy Services, Inc. on May 31, 2001 for $27.34 million. | Contract Drilling | Director of Finance/CFO | |
OREXO AB | Pharmaceuticals: Major | Director/Board Member | |
The Johns Hopkins University | College/University | Graduate Degree | |
University of Toronto | College/University | Undergraduate Degree | |
Virginia Polytechnic Institute & State University | College/University | Undergraduate Degree | |
BMO Nesbitt Burns, Inc.
BMO Nesbitt Burns, Inc. Financial ConglomeratesFinance BMO Nesbitt Burns, Inc. provides investment and financial advisory services. The firm offers financial planning; estate planning and preservation; retirement, insurance, and education planning; income replacement; tax minimization; and business succession planning advisory services. The company was founded in 1912 and is headquartered in Toronto, Canada. | Financial Conglomerates | Director of Finance/CFO | |
KPMG, Inc. (Canada)
KPMG, Inc. (Canada) Miscellaneous Commercial ServicesCommercial Services Part of KPMG International Cooperative, KPMG, Inc. (Canada) is a company based in Calgary, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Chartered Professional Accountants of Ontario
Chartered Professional Accountants of Ontario Miscellaneous Commercial ServicesCommercial Services Chartered Professional Accountants of Ontario engages in the provision of accounting education. It offers certification, continued trainings, and professional development. The company was founded in 2014 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Thomson Linear LLC
Thomson Linear LLC Metal FabricationProducer Manufacturing Thomson Linear LLC manufactures linear motion control products. The company was founded on October 13, 2000 and is headquartered in Marengo, IL. | Metal Fabrication | Director of Finance/CFO | |
Institute of Corporate Directors
Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Fanshawe College | College/University | Undergraduate Degree | |
Johnson & Johnson Medical, Inc.
Johnson & Johnson Medical, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Johnson & Johnson Medical, Inc. is a company that manufactures surgical appliances. The company is based in Arlington, TX. | Medical Specialties | Director of Finance/CFO | |
Archean Energy Ltd. | Director of Finance/CFO | ||
RF CAPITAL GROUP INC. | Investment Banks/Brokers | Director/Board Member | |
Hydrogenics Europe NV
Hydrogenics Europe NV Industrial MachineryProducer Manufacturing Hydrogenics Europe engages in the design, building, and installation of hydrogen power systems. It offers industrial hydrogen generators, energy storage and fueling solutions, and fuel cell power systems. The company is headquartered in Westerlo, Belgium. | Industrial Machinery | Director/Board Member | |
SENSORION | Pharmaceuticals: Major | Chairman | |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Alvogen Korea Holdings Ltd.
Alvogen Korea Holdings Ltd. Pharmaceuticals: MajorHealth Technology Alvogen Korea Holdings Ltd. is a holding company, which engages in the development and manufacture of pharmaceutical products. Its products include medicine for urogenital system, circulatory system, diabetes, digestive system, nephrology division, dermatological division, respiratory system, antibiotics, hormone drug, health supplements, and pain reliever. The company was founded in 1958 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Director/Board Member | |
Rainier Therapeutics, Inc.
Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Chief Executive Officer | |
Antares Holdings LP
Antares Holdings LP Investment ManagersFinance Antares Holdings LP provides investment services. It offers financing solutions for middle-market and private equity-backed transactions. The company is headquartered in Toronto, Canada. | Investment Managers | Director/Board Member | |
CSL Ltd. (United States) | Corporate Officer/Principal | ||
HARPOON THERAPEUTICS, INC. | Biotechnology | Chairman | |
VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Antares Holdings GP, Inc.
Antares Holdings GP, Inc. Financial ConglomeratesFinance Antares Holdings GP, Inc. functions as an investment holding Canadian company and is ultimately controlled by the Government of Canada. The company is based in Toronto, Canada. | Financial Conglomerates | Director/Board Member | |
Project 1972, Inc.
Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Project 1972, Inc. engages in the provision of private networking platform for women. Its membership services include core group, salon series, connection, and clubhouses access. The company was founded by Lindsay Kaplan and Carolyn Childers in 2017 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
ALSP ORCHID ACQUISITION CORPORATION I | Financial Conglomerates | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 22 |
Canada | 22 |
Svezia | 3 |
Belgio | 3 |
Corea del Sud | 3 |
Settori
Health Technology | 19 |
Finance | 8 |
Commercial Services | 7 |
Consumer Services | 6 |
Energy Minerals | 4 |
Posizioni
Director/Board Member | 25 |
Director of Finance/CFO | 14 |
Independent Dir/Board Member | 10 |
Corporate Officer/Principal | 9 |
Chairman | 7 |
Contatti più connessi
Insiders | |
---|---|
David Ferguson | 22 |
Scott Myers | 18 |
Kevin Bain | 10 |
Stephanie C. Read | 7 |
Stefan Antonsson | 1 |
- Borsa valori
- Insiders
- Ildiko Mehes
- Connessioni Società